| Gene/Event | Cancer Type | Patient | Variant | Mutation Level |
|---|---|---|---|---|
| ATP2C2 | Breast Cancer | p111_p9-68 | p.A51G | Branch mutation |
| ATP2C2 | Breast Cancer | p143_p5 | Chr16:84480049:A>G | Private mutation |
| ATP2C2 | Colorectal Cancer | p034_MSU1 | Chr16:84472866:G>A | Trunk mutation |
| ATP2C2 | Colorectal Cancer | p034_MSU1 | Chr16:84486832:C>T | Private mutation |
| ATP2C2 | Colorectal Cancer | p034_MSU2 | Chr16:84494354:C>A | Trunk mutation |
| ATP2C2 | Colorectal Cancer | p034_MSU4 | Chr16:84485677:T>C | Trunk mutation |
| ATP2C2 | Colorectal Cancer | p040_case1 | Chr16:84495364:G>A | Branch mutation |
| ATP2C2 | Colorectal Cancer | p147_a20 | p.P578L | Trunk mutation |
| ATP2C2 | Esophageal Squamous Cell Carcinoma | p128_P18 | Chr16:84459366:G>A | Private mutation |
| ATP2C2 | Gastric Adenocarcinoma | p011_MSI-H1 | p.G257G | Trunk mutation |
| ATP2C2 | Gastric Adenocarcinoma | p011_MSI-H2 | p.P783P | Trunk mutation |
| ATP2C2 | Gastric Carcinoma | p106_GC09 | p.A333T | Private mutation |
| ATP2C2 | Glioblastoma | p070_HGG3 | Chr16:84488676:A>G | Private mutation |
| ATP2C2 | Glioma | p168_P90 | p.I326T | Private mutation |
| ATP2C2 | Lung Adenocarcinoma | p017_356 | Chr16:84494045:G>A | Branch mutation |
| ATP2C2 | Lung Adenocarcinoma | p083_X356 | - | Branch mutation |
| ATP2C2 | Medulloblastoma | p072_MB6 | Chr16:84473025:T>A | Private mutation |
| ATP2C2 | Melanoma | p043_A | p.G413E | Trunk mutation |
| ATP2C2 | Ovarian Serous Carcinomas | p006_OSC3 | p.V641L | Branch mutation |
| ATP2C2 | Ovarian Cancer | p144_AOCS064 | p.A804S | Private mutation |
| ATP2C2 | Ovarian Cancer | p144_AOCS094 | p.DIRL203D | Private mutation |
| ATP2C2 | Prostate Cancer | p164_P1 | p.A789G | Branch mutation |
| ATP2C2 | Prostate Cancer | p164_P2 | p.A789G | Branch mutation |
| ATP2C2 | Urothelial Carcinoma | p031_WCM077 | p.G236S | Private mutation |
| ATP2C2 | Urothelial Carcinoma | p031_WCM249 | p.G236S | Private mutation |